ArticleCell systems2018

Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes.

Spencer S Watson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.